Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
77M
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
12M
-
Shares change
-
+581K
-
Total reported value, excl. options
-
$95.2M
-
Value change
-
+$3.3M
-
Number of buys
-
34
-
Number of sells
-
-22
-
Price
-
$7.94
Significant Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q1 2017
72 filings reported holding CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value as of Q1 2017.
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12M shares
of 77M outstanding shares and own 15.57% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (2.16M shares), Cormorant Asset Management, LLC (1.94M shares), Rock Springs Capital Management LP (935K shares), FMR LLC (889K shares), Hillhouse Capital Management, Ltd. (855K shares), BlackRock Inc. (801K shares), PERCEPTIVE ADVISORS LLC (712K shares), VANGUARD GROUP INC (631K shares), FIRST MANHATTAN CO (350K shares), and AWM Investment Company, Inc. (341K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.